Human C1-esterase inhibitor Completed Phase 3 Trials for Hereditary Angioedema / Hereditary Angioedema (HAE) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02052141Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema